The Weekly Covid Vax Deaths and Adverse Events Report By Chris Knight (Florida)

The Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS), is the principal government-funded system for reporting adverse vaccine reactions in the U.S. New data showing a total of 1,379,438 reports of adverse events following COVID-19 vaccines were submitted between December 14, 2020, and August 5, 2022, an increase of 7,964 adverse events over last week. The data included a total of 30,162 reports of deaths, an increase of 181 over last week, and 251,075 serious injuries, including deaths, during the same time period, an increase of 1,959 compared with last week. Of the 30,162 reported deaths, 19,462 cases are attributed to Pfizer’s Covid-19 vaccine, 8,038 cases to Moderna, 2,613 cases to Johnson & Johnson (J&J). No cases have yet been reported for Novavax.

https://childrenshealthdefense.org/defender/cdc-quarantine-distancing-covid-vaccine-injuries-vaers/

“The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,379,438 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and Aug. 5, 2022, to the Vaccine Adverse Event Reporting System (VAERS). That’s an increase of 7,964 adverse events over the previous week.

VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.

The data included a total of 30,162 reports of deaths — an increase of 181 over the previous week — and 251,075 serious injuries, including deaths, during the same time period — up 1,959 compared with the previous week.

Of the 30,162 reported deaths, 19,462 cases are attributed to Pfizer’s COVID-19 vaccine, 8,038 cases to Moderna, 2,613 cases to Johnson & Johnson (J&J) and no cases yet reported for Novavax.

Excluding “foreign reports” to VAERS, 854,084 adverse events, including 13,972 deaths and 87,488 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Aug. 5, 2022.

Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 13,972 U.S. deaths reported as of Aug. 5, 7% occurred within 24 hours of vaccination, 15% occurred within 48 hours of vaccination and 54% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S., 604 million COVID-19 vaccine doses had been administered as of Aug. 3, including 357 million doses of Pfizer, 228 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).

Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.

VAERS data from Dec. 14, 2020, to Aug. 5, 2022, for 6-month-olds to 5-year-olds show:

• 2,975 adverse events, including 140 cases rated as seriousand 5 reported deaths.
• 4 reportsof myocarditis and pericarditis (heart inflammation).
  The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
• 20 reportsof blood clotting disorders.
• 38 reportsof seizures.

VAERS data from Dec. 14, 2020, to Aug. 5, 2022, for 5- to 11-year-olds show:

• 13,364 adverse events, including 620 rated as seriousand 22 reported deaths.
• 45 reportsof myocarditis and pericarditis.
• 64 reportsof blood clotting disorders.
• 169 reportsof seizures.

VAERS data from Dec. 14, 2020, to Aug. 5, 2022, for 12- to 17-year-olds show:

• 32,945 adverse events, including 4,189 rated as seriousand 118 reported deaths.
  According to the CDC, “VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.”
• 268 reportsof anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 94% of cases attributed to Pfizer’s vaccine.
• 1,304 reportsof myocarditis and pericarditis with 650 cases attributed to Pfizer’s vaccine.
• 298 reportsof blood clotting disorders with 275 cases attributed to Pfizer.
• 26 casesof postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.

VAERS data from Dec. 14, 2020, to Aug. 5, 2022, for all age groups combined, show:

• 20% of deaths were related to cardiac disorders.
• 55% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
• The average ageof death was 73.
• As of Aug. 5, 12,010 pregnant womenreported adverse events related to COVID-19 vaccines, including 4,801 reports of miscarriage or premature birth.
• Of the 16,124 cases of Bell’s Palsyreported, 75% were attributed to Pfizer vaccinations, 23% to Moderna and 4% to J&J.
• 2,881 reports of Guillain-Barré syndrome, with 66% of cases attributed to Pfizer, 20% to Moderna and 17% to J&J.
• 9,884 reportsof anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
• 4,663 reportsof myocardial infarction.
• 42,180 reportsof blood-clotting disorders in the U.S. Of those, 28,921 reports were attributed to Pfizer, 9,445 reports to Moderna and 3,754 reports to J&J.
• 23,535 casesof myocarditis and pericarditis with 17,890 cases attributed to Pfizer, 5,226 cases to Moderna and 399 cases to J&J.
• 64 casesof Creutzfeldt-Jakob disease with 51 cases attributed to Pfizer, 12 cases to Moderna and 1 case to J&J.
• 493 casesof POTS with 375 cases attributed to Pfizer, 109 cases to Moderna and 21 cases to J&J.